Condition: Moyamoya Disease
rs9902358 in
CARD14 gene and
Moyamoya Disease
PMID 29273593 2018 Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
rs11640018 in
CFDP1 gene and
Moyamoya Disease
PMID 29273593 2018 Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
rs201661014 in
DOCK9 gene and
Moyamoya Disease
PMID 29273593 2018 Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
rs3735925 in
FBXO25 gene and
Moyamoya Disease
PMID 29273593 2018 Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
rs6958010 in
JAZF1 gene and
Moyamoya Disease
PMID 29273593 2018 Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
rs9614159 in
LOC105372988;HORMAD2 gene and
Moyamoya Disease
PMID 29273593 2018 Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
rs118177209 in
LOC105378178 gene and
Moyamoya Disease
PMID 29273593 2018 Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
rs4759277 in
LRP1 gene and
Moyamoya Disease
PMID 29273593 2018 Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
rs74388387 in
MAGI2 gene and
Moyamoya Disease
PMID 29273593 2018 Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
rs9651118 in
MTHFR gene and
Moyamoya Disease
PMID 29273593 2018 Two novel SNPs in genes regulating homocysteine metabolism, rs9651118 in <i>MTHFR</i> (<i>P</i><sub>combined</sub>=2.49×10<sup>-19</sup>; odds ratio, 0.65) and rs117353193 in <i>TCN2</i> (<i>P</i><sub>combined</sub>=6.15×10<sup>-13</sup>; odds ratio, 1.43), were associated with high-serum homocysteine in MMD cases.
rs2071213 in
MYRF gene and
Moyamoya Disease
PMID 29273593 2018 Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
rs2262994 in
NLN gene and
Moyamoya Disease
PMID 29273593 2018 Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
rs2273291 in
PLOD1 gene and
Moyamoya Disease
PMID 29273593 2018 Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
rs16861137 in
RAPGEF4 gene and
Moyamoya Disease
PMID 29273593 2018 Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
rs10782008 in
RNF213 gene and
Moyamoya Disease
PMID 29273593 2018 Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
PMID 29273593 2018 One SNP, rs9916351 in <i>RNF213</i> (<i>P</i><sub>combined</sub>=4.57×10<sup>-54</sup>; odds ratio, 1.96), showed a stronger genetic effect on early-onset than late-onset MMD (<i>P</i>=0.003).
rs6565681 in
RNF213-AS1;RNF213 gene and
Moyamoya Disease
PMID 21048783 2011 A genome-wide association study identifies RNF213 as the first Moyamoya disease gene.
rs4969426 in
RPTOR gene and
Moyamoya Disease
PMID 29273593 2018 Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
rs10734650 in
SBF2 gene and
Moyamoya Disease
PMID 29273593 2018 Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
rs3813803 in
SMPDL3B gene and
Moyamoya Disease
PMID 29273593 2018 Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
rs117353193 in
TCN2 gene and
Moyamoya Disease
PMID 29273593 2018 Two novel SNPs in genes regulating homocysteine metabolism, rs9651118 in <i>MTHFR</i> (<i>P</i><sub>combined</sub>=2.49×10<sup>-19</sup>; odds ratio, 0.65) and rs117353193 in <i>TCN2</i> (<i>P</i><sub>combined</sub>=6.15×10<sup>-13</sup>; odds ratio, 1.43), were associated with high-serum homocysteine in MMD cases.
rs16862676 in
TSC22D2 gene and
Moyamoya Disease
PMID 29273593 2018 Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.